IDYA
Ideaya Biosciences Inc
36.30$
-1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | +17.9% | -31.4% | +20.8% | +2.5% | -67.0% | +283.4% | -48.5% | +407.6% | -86.5% | +95.9% | -55.0% | +126.8% | -51.2% | -100.0% | – | – | – | -100.0% | – | – | -94.8% | -39.7% | +35.0% | – | |
| – | +7.3% | -3.4% | +43.0% | +2.4% | +1.7% | +0.7% | +10.0% | +1.8% | +19.0% | -29.0% | +27.1% | +3,103.9% | +29.5% | +3.5% | -97.3% | +9.2% | +159.5% | -23.2% | -39.7% | +72.0% | +4.0% | -1.2% | +3.9% | +5.7% | +1.4% | -7.7% | -36.5% | +10,924.3% | +4.7% | +11.8% | +4.3% | +10.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +17.6% | -142.3% | – | – | – | +329.3% | -57.3% | +519.2% | -88.0% | +99.8% | -63.2% | +177.0% | -58.9% | -137.3% | – | – | – | -1,215.1% | – | – | -160.7% | – | – | – | |
| – | +23.6% | +94.9% | -39.6% | +5.5% | +10.8% | +0.7% | -4.3% | +5.7% | -4.8% | +16.6% | +20.2% | -4.0% | +29.5% | +3.5% | +3.9% | +22.0% | +16.0% | -1.9% | +10.5% | +12.7% | +4.7% | +15.5% | +15.0% | +10.4% | +27.4% | +4.8% | +145.3% | -49.4% | +4.7% | +11.8% | +4.3% | +10.5% | +13.5% | – | |
| – | +28.7% | -4.5% | +43.0% | +34.8% | +13.3% | +13.6% | +2.9% | +24.3% | +15.7% | -1.4% | -3.5% | +26.7% | +0.2% | +7.4% | +0.7% | +13.4% | -6.2% | +20.0% | -13.7% | +9.5% | +12.3% | +11.1% | -10.1% | +16.2% | +26.6% | -6.3% | +12.5% | +23.3% | +8.0% | +12.4% | +15.0% | +2.8% | +15.9% | – | |
| – | +24.9% | +82.3% | -32.0% | +7.3% | +11.6% | +3.5% | -2.9% | +10.5% | +0.4% | +12.1% | +13.4% | -68.9% | +0.2% | +7.4% | +303.1% | +20.1% | +8.1% | +3.6% | +6.4% | +11.0% | +6.2% | +15.1% | +10.4% | +13.8% | +25.1% | +3.2% | +128.4% | -91.0% | +8.0% | +12.4% | +15.0% | +2.8% | +576.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4,106.7% | – | – | – | – | – | – | – | – | – | – | – | -187.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -54.3% | -64.8% | +1,112.9% | -86.6% | -8.8% | +235.6% | +5,666.5% | -99.0% | +114.0% | +115.6% | +134.8% | +60.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,598.5% | – | – | – | – | – | – | – | – | – | – | – | -169.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -45,481.8% | – | – | -123.5% | – | – | – | – | – | – | -119.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,598.5% | – | – | – | – | – | – | – | – | – | – | – | -169.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,030.8% | – | – | – | – | – | – | – | – | – | – | – | -185.3% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.